Immunome Cash Flow Statement (2023-2025) | IMNM

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -4.47M-5.77M-4.63M-94.65M-132.30M-40.01M-50.52M-82.97M-44.64M-46.48M-60.14M
Share-based Compensation 1.22M1.03M1.08M2.88M2.16M3.23M4.89M5.47M5.70M5.35M6.75M
Gains from Investment Securities 2.49M3.04M3.02M5.80M8.53M3.40M2.20M2.20M0.35M0.10M0.30M
Non-cash Items 7.60M1.56M1.67M45.36M146.17M2.74M72.20M75.20M3.56M3.92M4.97M
Cash from Operations 24.17M-5.67M-8.61M-17.46M-11.17M-23.40M-34.17M-42.06M-53.05M-49.40M-40.51M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.05M0.06M-0.44M0.84M0.54M0.35M1.47M0.54M0.82M1.21M0.82M
Depreciation & Amortization (CF) 0.09M0.10M0.11M0.19M0.16M0.55M0.41M0.48M0.61M0.64M0.59M
Change in Working Capital
Change in Account Payables 0.69M0.59M-1.21M-0.68M2.40M-0.03M-2.11M9.27M-3.81M-4.95M1.87M
Change in Accured Expenses -1.40M1.37M-1.42M2.07M0.67M6.90M5.94M0.04M-8.52M0.62M6.74M
Other Working Capital Changes 802.00-4.26M-3.56M-3.83M0.09M-0.92M-2.91M-2.74M0.11M-4.01M
Investing Activities
Capital Expenditures 0.22M0.22M0.04M0.35M2.16M2.34M1.54M1.13M3.67M0.91M1.12M
Change in Intangibles 15.01M
Change in Acquisitions & Divestments 30.00M85.00M15.00M60.00M125.00M
Cash from Investing Activities -0.11M-0.34M-0.04M-30.00M-37.23M-81.69M24.10M9.76M5.09M-64.17M123.88M
Financing Activities
Cash from Financing Activities 0.03M60.88M55.50M219.44M0.69M0.30M20.09M162.23M-0.06M45.39M
Additional items
Change in Cash 24.10M-6.01M52.23M8.04M171.04M-104.39M-9.76M-12.22M114.26M-113.63M128.76M
Beginning Cash Balance 20.32M44.42M38.42M90.64M98.68M269.72M165.33M155.57M143.35M257.53M143.88M
Free Cash Flow 23.95M-5.89M-8.65M-17.81M-13.33M-25.74M-35.71M-43.19M-56.72M-50.31M-41.63M
Net Cash Flow 24.10M-6.01M52.23M8.04M171.04M-104.39M-9.76M-12.22M114.26M-113.63M128.76M